R&D
A practical route through regulatory uncertainty in clinical...
Organisations must remain agile and decisive across global portfolios, anticipating regulatory changes before they create clinical trial delays.
Patients
Sponsored
12 Questions with Kim Innes
Kim Innes is General Manager of Teva UK. She has more than 30 years’ experience across the pharmaceutical industry.
Oncology
Key lessons from EHA 2026: Translating evidence into impact
Across four days in Sweden, EHA 2026 offered a clear view of the future of blood cancer care.
Digital
Building agentic AI in healthcare
Healthcare organisations can’t afford to ignore agentic AI, but they also can’t afford to deploy it without the infrastructure to use it responsibly.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
